5 news items
Why Nurix Therapeutics Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket
AAN
AMCX
BIMI
17 Jun 24
chronic lymphocytic leukemia.
Nurix Therapeutics shares jumped 12.1% to $17.01
ENDRA Life Sciences Announces Pricing of $8.0 Million Public Offering
NDRA
4 Jun 24
known as NAFLD-NASH) is a chronic liver disease spectrum that affects over two billion people globally, and for which there are no practical
ENDRA Provides Update Following In-person Meeting with FDA
NDRA
20 May 24
in the liver. Steatotic liver disease (SLD, formerly known as NAFLD-NASH) is a chronic liver disease spectrum that affects over two billion people
ENDRA Life Sciences Reports First Quarter 2024 Financial Results and Provides a Business Update
NDRA
14 May 24
as a means to assess and monitor steatotic liver disease (SLD) (formerly known as NAFLD-NASH), a chronic liver disease spectrum that affects over two billion
ENDRA Life Sciences to Report First Quarter 2024 Financial Results on May 14, 2024
NDRA
7 May 24
focused on the measurement of fat in the liver as a means to assess and monitor steatotic liver disease (SLD) (formerly known as NAFLD-NASH), a chronic
- Prev
- 1
- Next